In conclusion, our study revealed that the mRNA expression and the protein level of GALNT2 were increased in cervical cancer, and concomitant high expressions of GALNT2 and specific cytokines, chemokines or immune modulatory molecules could predicte patients’ unfavorable survival in cervical cancer. The gene discussed is GALNT2; the disease is cervical cancer.